Changes in Respiratory Care Use During the COVID-19 Pandemic in a Pediatric Long-Term Care Facility.

IF 1.1 4区医学 Q4 ALLERGY

Pediatric Allergy Immunology and Pulmonology Pub Date : 2025-06-23 DOI:10.1089/ped.2024.0125

Rose Hawkins, Corrie Harris, Heather Huxol, Scott Bickel, Mary Elise McClanahan, Theresa Kluthe, Ronald Morton

{"title":"Changes in Respiratory Care Use During the COVID-19 Pandemic in a Pediatric Long-Term Care Facility.","authors":"Rose Hawkins, Corrie Harris, Heather Huxol, Scott Bickel, Mary Elise McClanahan, Theresa Kluthe, Ronald Morton","doi":"10.1089/ped.2024.0125","DOIUrl":null,"url":null,"abstract":"Background: The COVID-19 pandemic impacted multiple aspects of care at pediatric long-term care facilities (pLTCFs). This study evaluated the effect of COVID-19 infection control policies on pLTCF resident's respiratory health. Methods: A retrospective study of 76 residents' oxygen, albuterol, hypertonic saline (HTS), and pulmonary hygiene treatment use from January 2019 to December 2022 was completed using de-identified billing data and chart review. Results: There was a statistically significant increase in rate of oxygen use among residents (5.67; 95% CI 3.44-7.8; P < 0.001) during the study period, but at a slower rate than expected by the pre-pandemic trend (-4.89; 95% CI -7.20-2.59; P < 0.001). HTS use decreased during the study period, with a change in the prior trend to downward (-3.43; -5.89-9.68; P = 0.007). There was no significant change in albuterol or pulmonary hygiene treatment. Conclusions: This study demonstrates that patterns of oxygen and HTS use in a pLTCF changed during the COVID-19 pandemic.","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Allergy Immunology and Pulmonology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ped.2024.0125","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The COVID-19 pandemic impacted multiple aspects of care at pediatric long-term care facilities (pLTCFs). This study evaluated the effect of COVID-19 infection control policies on pLTCF resident's respiratory health. Methods: A retrospective study of 76 residents' oxygen, albuterol, hypertonic saline (HTS), and pulmonary hygiene treatment use from January 2019 to December 2022 was completed using de-identified billing data and chart review. Results: There was a statistically significant increase in rate of oxygen use among residents (5.67; 95% CI 3.44-7.8; P < 0.001) during the study period, but at a slower rate than expected by the pre-pandemic trend (-4.89; 95% CI -7.20-2.59; P < 0.001). HTS use decreased during the study period, with a change in the prior trend to downward (-3.43; -5.89-9.68; P = 0.007). There was no significant change in albuterol or pulmonary hygiene treatment. Conclusions: This study demonstrates that patterns of oxygen and HTS use in a pLTCF changed during the COVID-19 pandemic.

查看原文本刊更多论文

COVID-19大流行期间儿科长期护理机构呼吸保健使用的变化

背景：2019冠状病毒病大流行影响了儿科长期护理机构（pltcf）护理的多个方面。本研究旨在评估新冠肺炎感染控制政策对pLTCF居民呼吸健康的影响。方法：回顾性研究2019年1月至2022年12月76名居民的氧、沙丁胺醇、高渗盐水（HTS）和肺部卫生治疗使用情况，采用去识别计费数据和图表回顾。结果：居民吸氧率有统计学意义的上升(5.67；95% ci 3.44-7.8；P < 0.001)，但速度低于大流行前趋势所预期的速度(-4.89；95% ci -7.20-2.59；P < 0.001)。在研究期间，HTS的使用减少了，并改变了先前的下降趋势(-3.43；-5.89 - -9.68;P = 0.007)。沙丁胺醇或肺部卫生治疗无明显变化。结论：本研究表明，在COVID-19大流行期间，pLTCF的氧气和HTS使用模式发生了变化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Allergy Immunology and Pulmonology ALLERGY-IMMUNOLOGY

CiteScore

2.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Pediatric Allergy, Immunology, and Pulmonology is a peer-reviewed journal designed to promote understanding and advance the treatment of respiratory, allergic, and immunologic diseases in children. The Journal delivers original translational, clinical, and epidemiologic research on the most common chronic illnesses of children—asthma and allergies—as well as many less common and rare diseases. It emphasizes the developmental implications of the morphological, physiological, pharmacological, and sociological components of these problems, as well as the impact of disease processes on families. Pediatric Allergy, Immunology, and Pulmonology coverage includes: -Functional and genetic immune deficiencies- Interstitial lung diseases- Both common and rare respiratory, allergic, and immunologic diseases- Patient care- Patient education research- Public health policy- International health studies